TOLL BIOTECH
Toll Biotech is a drug research and development company that develops a series of small molecules for Toll-like receptor (TLR) targets. It was established in April 2020 and is initiated by the team of Professor Yin Hang, School of Pharmacy, Tsinghua University.
TOLL BIOTECH
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2020-04-01
Address:
Beijing, Beijing, China
Country:
China
Status:
Active
Total Funding:
10 M CNY
More informations about "Toll Biotech"
Toll Biotech - VentureRadar
"Toll Biotech is a Chinese startup founded in 2020 to develop small molecule drugs, with new targets and new mechanisms of action, for autoimmune diseases. The company was founded …See details»
Toll Biotech Co.Ltd. (Beijing) - Drug pipelines, Patents ... - Patsnap
Explore Toll Biotech Co.Ltd.(Beijing) with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, and 1 literature, Disease Domain:Immune System Diseases, Technology …See details»
Toll Biotech - Funding, Financials, Valuation & Investors
Toll Biotech is a drug research and development company that develops a series of small molecules for Toll-like receptor (TLR) targets.See details»
Toll Biotech - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Toll Biotech. Use the PitchBook Platform to explore the full profile.See details»
Toll Biotech Co. Ltd. Company Profile | Beijing, Beijing, China ...
Find company research, competitor information, contact details & financial data for Toll Biotech Co. Ltd. of Beijing, Beijing. Get the latest business insights from Dun & Bradstreet.See details»
Toll Biotech - Crunchbase
Toll Biotech is a drug research and development company that develops a series of small molecules for Toll-like receptor (TLR) targets.See details»
Beijing Toll Biotech Co., Ltd. - Drug pipelines, Patents, Clinical ...
Explore Beijing Toll Biotech Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Toll Biotech has Obtained A-round Financing of Over 100 Million …
Recently, Beijing Toll Biotech Co., Ltd. (“Toll Biotech”) announced its completion of A-round financing of over 100 million yuan. ZGC Collaborative Innovation Direct Investment Fund, a …See details»
Toll Biotech - CoBee Company Profile & Funding Rounds
Toll Biotech is a drug research and development company that develops a series of small molecules for Toll-like receptor (TLR) targets. It was established in April 2020 and is initiated …See details»
TollB-001 - Drug Targets, Indications, Patents - Synapse - Patsnap
2 days ago TollB-001: a TLR8 modulators Drug, Initially developed by Toll Biotech Co.Ltd. (Beijing), Now, its global highest R&D status is Phase 1, Mechanism: TLR8 modulators (Toll …See details»
Medicilon Assists Toll Biotech's TollB-001 tablets, a new class 1.1 ...
Jun 21, 2023 Recently, the IND application of TollB-001 Tablets, a class 1.1 new drug for rheumatoid arthritis by Toll Biotech, has been officially approved by the FDA. Medicilon …See details»
Toll Biotech - Tech Stack, Apps, Patents & Trademarks
Toll Biotech is a drug research and development company that develops a series of small molecules for Toll-like receptor (TLR) targets.See details»
Toll Biotech Completed A Round of Financing to Accelera...
Recently, Toll Biotech announced the completion of A round of financing of more than 100 million yuan. This round of financing is to help Toll Biotech develop its own Class I new drugs for …See details»
TollB-002 - Drug Targets, Indications, Patents - Synapse
Jan 4, 2025 TollB-002: a TLR modulators Drug, Initially developed by Toll Biotech Co.Ltd. (Beijing), Now, its global highest R&D status is Preclinical, Mechanism: TLR modulators (Toll …See details»
TollB 001 - AdisInsight - Springer
TollB 001 is a small molecule being developed by Beijing Toll Biotech for the treatment of rheumatoid arthritis. Clinical development is underway in China.See details»
TollB-001 tablets in Rheumatoid Arthritis - Clinical Trials ... - ICH GCP
Sep 22, 2023 The primary objective is to evaluate the safety and tolerability of TollB-001 following the administration of single or multiple oral doses in healthy adult sub...See details»
Angel Round - Toll Biotech - 2021-03-18 - Crunchbase
Overview Edit Overview Section Organization Name Toll Biotech Announced DateMar 18, 2021 Funding TypeAngel Funding StageSeed Money RaisedCN¥10MSee details»
CU-CPT-9s - Drug Targets, Indications, Patents - Synapse
CU-CPT-9s: a TLR8 antagonists Drug, Initially developed by Toll Biotech Co.Ltd. (Beijing), Now, its global highest R&D status is Preclinical, Mechanism: TLR8 antagonists (Toll like receptor 8 …See details»
Toll PATEO - Crunchbase Company Profile & Funding
Toll PATEO is a natural science, medical research and experimental development service provider.See details»